Page 75 - GALENIKA MEDICAL JOURNAL
P. 75

hypoglycemia presents with tachycardia, restlessness, con-  extended  period  because  the  goal  is  not  to  achieve  nor-
            fusion,  and  irritability,  accompanied  by  sweating,  pallor,   moglycemia instantly (which is not possible anyway, as the
            and tremors. Severe hypoglycemia is marked by hypoten-  number  and  sensitivity  of  insulin  receptors  are  limited) .
                                                                                                             29
            sion and loss of consciousness. According to our National   During DKA therapy, it's essential to frequently repeat la-
            Guidelines  for  the  Diagnosis  and  Treatment  of  Diabetes   boratory tests, and monitoring of electrocardiogram (EKG)
            Mellitus, for grades 1-2 (mild/moderate hypoglycemia), the   is necessary if potassium levels are too low or too high (< 3
            recommended  treatment  is  to  administer  2-4  glucose  ta-  mmol/L or > 6 mmol/L). Fractionated bolus doses of short-
            blets or two teaspoons (10 g) of sugar, honey, or jam, or a   acting insulin can be used in DKA therapy, but continuous
            small bottle of juice containing sugar. For grades 3-4 (seve-  intravenous  infusion  of  this  insulin  is  recommended.  Bi-
            re hypoglycemia), the recommended therapy is parenteral:   carbonate  replacement  in  DKA  treatment  should  be  very
            slow intravenous bolus or infusion of glucose (25 mL of 50%   cautious and limited to cases where metabolic acidosis is
            or 100 mL of 20% solution). This therapy raises the blood su-  severe (bicarbonate level < 8 mmol/L or pH < 7.0) . The fun-
                                                                                                       8
            gar level by 12.5 mmol/L within five minutes, making it the   damental requirement for successful DKA treatment is con-
            best way to manage severe hypoglycemia. However, cauti-  tinuous monitoring and care of the patient during the first
            on is needed as extravascular administration can cause ne-  24 hours of therapy.
            crosis. An alternative to glucose is glucagon (1 mg = 1 unit),
            which can be administered intravenously, intramuscularly,   Certainly, the most important aspect is the prevention
            or subcutaneously. However, this therapy may be ineffective   of these complications, and in this context, as part of the
            if the patient has been fasting or consuming alcohol for an   pre-procedural  preparation  for  dental  interventions,  pa-
            extended period (as glycogen stores for glucose mobiliza-  tients should receive advice on the importance of regular
            tion may be depleted). Therefore, it is necessary for dental   check-ups  with  an  endocrinologist,  maintaining  a  proper
            offices to be equipped following the recommendations of   dietary regimen, especially for particularly vulnerable cate-
            the National Guide and to always have available (in addition   gories of diabetic patients such as children, pregnant wo-
            to the equipment for measuring blood glucose levels in ca-  men, and elderly patients 38-40 .
            pillary blood): a sugar cube or chocolate, fruit juice, or ano-
            ther sweetened beverage, and a glucagon injection kit 8, 37 . It
            is recommended that during dental procedures in patients
            with diabetes, verbal contact should be maintained conti-
            nuously, and if hypoglycemia has occurred (which has been
            successfully managed), such patients should be monitored
            in the dental office for at least another hour.

               The therapy for DKA is complex. In cases of milder DKA
            (conscious patient, good general condition), attempts can
            be made with oral rehydration and subcutaneous injections
            of regular or rapid-acting insulin. However, for severe forms
            of DKA, therapy is exclusively parenteral (intravenous) and
            requires  laboratory  and  other  monitoring,  making  it  un-
            suitable for administration in a dental office. Hospitalizati-
            on is necessary in such cases. Therefore, it is important to
            promptly suspect DKA in a dental to arrange for the patient's
            transport to the hospital. Unfortunately, the symptoms and
            signs of DKA are not particularly specific, necessitating la-
            boratory  confirmation.  DKA  presents  with  a  sensation  of
            dryness  in  the  mouth,  thirst,  general  weakness,  fatigue,
            exhaustion, anorexia, decreased sweating, and possible na-
            usea and vomiting. Various levels of consciousness distur-
            bances may also occur, depending on the severity of DKA.
            However, assessing the severity of DKA without laboratory
            analysis, particularly gas analysis (blood pH and serum bi-
            carbonate), is difficult. Therefore, the primary guide in the
            clinical assessment of DKA severity is the patient's level of
            consciousness 27, 29 .

               The treatment for DKA, as per the National Guidelines,
            involves rehydration, electrolyte replacement (primarily po-
            tassium), insulin administration, and other measures . Fluid
                                                      8
            and electrolyte replacement must be done slowly over an


            REVIEW PAPER                                                      Galenika Medical Journal, 2024; 3(9):69-75.  73
   70   71   72   73   74   75   76   77   78   79   80